Towards Healthcare

Top Companies

Your marketplace is evolving, your competitors are readjusting – but instead of reacting you can proact

Weight Management Companies, Recent Strategic Partnerships, Operational Enhancements, Strategic Resource Allocation, Intellectual Property (IP) Portfolio Management, Financial Performance Evaluation

The weight management companies are Herbalife Ltd., Weight Watchers International, Jenny Craig, Medifast Inc., Atkins Nutritionals, Inc., Nestlé, Kellanova, Johnson & Johnson Services, Inc., Olympus Corporation, Medifast Inc., Nutrisystem Ltd.

29 November 2024

Alopecia Areata Key Players, Recent Strategic Partnerships, Market Entry and Expansion Strategies, IP Valuation, Leadership and Governance, Risk Mitigation

The alopecia areata companies are Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline Plc., Johnson & Johnson Services Inc., Bayer AG, Dr. Reddy's Laboratories Ltd.,Viatris Inc., AstraZeneca and Abbott Laboratories.

29 November 2024

Medical Imaging Reagents Key Players, Recent Strategic Partnerships, Operational Excellence, Deal Structuring, Patent Expansions

The medical imaging reagents companies are Thermo Fisher Scientific Inc, Canon Medical Systems Corporation, Fujifilm, GE Healthcare, Siemens Healthineers, Hitachi Medical, Hologic, Philips Healthcare, Roche, Carestream Health, Qiagen and Abbott Laboratories.

28 November 2024

Arthroscopy Devices Companies, Market Position Advancements, Strategic Resource Allocation, Cross-border Expansion & Patent Expansion

The arthroscopy devices companies are Arthrex, B. Braun, CONMED Corporation, DePuy Synthes, Endomed Systems, Fiegert Endotech, Karl Storz GmBH, Lepu Medical, Medtronic plc, Pioneer Healthcare Technologies, Richard Wolf, Smith & Nephew, Stryker Corporation, Wellcare Medical Systems and Zimmer Biomet.

28 November 2024

Newborn Screening Companies Innovation and Product Evolution, Operational Excellence, Strategic Joint Ventures, Financial Performance Evaluation & Future Market Positioning

The newborn screening companies are Bio-Rad Laboratories Inc., Agilent Technologies Inc., Natus Medical Inc., Waters, Siemens Healthineers AG, Bruker, GE HealthCare, Medtronic, Trivitron Healthcare and Masimo Corporation.

28 November 2024

Exosome Diagnostic and Therapeutic Companies | Corporate Milestones | Recent Strategic Partnerships | Cross-border Expansion

The exosome diagnostic and therapeutic market key players are Thermo Fisher Scientific Inc., Exosome Diagnostics, QIAGEN, System Biosciences LLC, ReNeuron, Hitachi Chemical Diagnostics Inc., Capricor Therapeutics Inc., Evox Therapeutics, Bio-Techne, Capital Biosciences Inc., Exogenus Therapeutics and Exo Biologics.

27 November 2024

Glutamine Top Manufacturers | Recent Developments | Operational Excellence | Patent Filing and Protection | Leadership and Governance

The glutamine key players are Kyowa Hakko Kirin Co., Ltd., Ajinomoto Co., Inc., Evonik Industries AG, Metabolic Technologies, Inc., Fufeng Group, Nutritech, Battery Nutrition Limited, Allmax Nutrition INC., Nutri Advanced Ltd and Optimum Nutrition.

27 November 2024

Atrial Fibrillation Treatment Companies-Recent Strategic Partnerships, Investment and Capital Allocation, IP Valuation, Leadership Alignment with Trends

The Atrial fibrillation treatment companies are Boston Scientific Corporation, Johnson & Johnson Med Tech, Pfizer, Bristol Myers Squibb, Boehringer Ingelheim Bayer, Novartis, AtriCure, Inc., Medtronic and Abbott.

27 November 2024

Cell Separation Technologies Companies | Technological Advancements | Value Creation | Cross-border Expansion | Patent Expansions | Market Trends Analysis

The cell separation technologies companies are Akadeum Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bristol Myers Squibb, Cellares, Duoning Biotechnology Group, Danaher Corporation, GE Healthcare, Merck, Miltenyi Biotec, STEMCELL Technologies, Terumo Corporation and Thermo Fisher Scientific.

26 November 2024

Upstream Bioprocessing Companies | Operational Enhancements | Competitive Positioning | Deal Structuring | Financial Performance Evaluation | Long-Term Forecasts

The upstream bioprocessing key players are Thermo Fisher Scientific, Inc., Merck KGaA, Corning Incorporated, Sartorius AG, Eppendorf AG, Danaher, Boehringer Ingelheim GmbH, Applikon Biotechnology, PBS Biotech, Inc., Lonza, VWR International, LLC, Meissner Filtration Products, Inc., Repligen Corporation, Entegris and Kuhner AG.

26 November 2024

Showing 461 to 470 of 478 companies